Search for: "Federal, Inc." Results 741 - 760 of 57,383
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Apr 2011, 5:31 pm
California - In In re BP Lubricants USA Inc., the Federal Circuit Court of Appeals held that a false marking claim must satisfy the particularity standard of Fed.R.Civ.P. 9(b), which requires that complaints alleging fraud or mistake "state with particularity the circumstances constituting fraud or mistake. [read post]
24 May 2011, 2:10 pm by Eric Schweibenz
On May 23, 2011, the Federal Circuit issued its opinion in Tessera, Inc. v. [read post]
28 Oct 2018, 3:45 am by Steve Brachmann
The Federal Circuit recently issued a nonprecedential decision in BASF Corporation v. [read post]
4 Sep 2020, 4:15 am by Brandon Reed
The United States Court of Appeal for the Federal Circuit recently upheld the Central District of California’s ruling of summary judgment that certain accused products of Foundation Constructors, Inc. and Foundation Pile, Inc. [read post]
The case is pending before the Maryland Court of Appeals on a question certified from a Maryland federal court in a COVID-19 business interruption insurance lawsuit brought by clothing manufacturer, Tapestry, Inc. [read post]
The federal district court in Alexandria did not err in finding that a German company’s mark VAGISAN used on feminine care products was likely to cause confusion with Combe, Inc. [read post]
12 Dec 2011, 9:59 pm by Patent Docs
Noonan -- The Federal Circuit reversed the grant of a preliminary injunction in Warner Chilcott Labs. [read post]
20 Dec 2011, 6:58 am by Al Raymond
The Federal District Court for the District of Maine’s August 3, 2011 decision to adopt U.S. [read post]
26 Aug 2009, 9:59 pm
Plaintiff-Appellant Ortho-McNeil Pharmaceutical, Inc. owns the '221 patent, which relates to a tramadol and acetaminophen composition for use in prescription pain relief. [read post]
12 Oct 2010, 9:59 pm by Patent Docs
§ 2201) in the Hatch-Waxman context in Teva Pharmaceuticals USA, Inc. v. [read post]
24 Feb 2009, 9:43 pm
Food and Drug Administration from approving the Abbreviated New Drug Application (ANDA) filed by Defendant-Appellant Teva Pharmaceuticals USA, Inc. [read post]
7 Jun 2010, 9:59 pm by Patent Docs
Par Pharmaceutical, Inc., the Federal Circuit exercised its prerogative to illustrate its fractured jurisprudence on two issues, obviousness and inequitable conduct, in a (fortunately) nonprecedential decision. [read post]
6 Sep 2011, 9:55 pm by Patent Docs
Noonan -- The Federal Circuit majority decision in Classen Immunotherapies, Inc. v. [read post]
3 Jul 2012, 7:41 am by The Federalist Society
Federal Election Commission, which struck down a ban in federal law against corporate spending in political campaigns. [read post]